Search Results - "Litvinova Svetlana, A."

Pharmacological Analysis of GABAA Receptor and Sigma1R Chaperone Interaction: Research Report I―Investigation of the Anxiolytic, Anticonvulsant and Hypnotic Effects of Allosteric GABAA Receptors’ Ligands by Voronin, Mikhail V., Shangin, Stanislav V., Litvinova, Svetlana A., Abramova, Elena V., Kurbanov, Rustam D., Rybina, Inna V., Vakhitova, Yulia V., Seredenin, Sergei B.

“…Two groups of facts have been established in previous drug development studies of the non-benzodiazepine anxiolytic fabomotizole. First, fabomotizole prevents…”
Get full text

Levetiracetam effect and electrophysiological mechanism of action in rats with cobalt-induced chronic epilepsy by Litvinova Svetlana, A., Voroninа Tatyana, A., Nerobkova Lubov, N., Kutepova Inga, S., Avakyan Georgii, G., Avakyan Gagik, N.

“…Levetiracetam was initially developed as a nootropic drug, although since 2002 it has been used as anticonvulsant for the treatment of partial and generalized…”
Get full text

Transcriptome of the Krushinsky-Molodkina Audiogenic Rat Strain and Identification of Possible Audiogenic Epilepsy-Associated Genes by Chuvakova, Lyubov N., Funikov, Sergei Yu, Rezvykh, Alexander P., Davletshin, Artem I., Evgen’ev, Michael B., Litvinova, Svetlana A., Fedotova, Irina B., Poletaeva, Inga I., Garbuz, David G.

“…Audiogenic epilepsy (AE), inherent to several rodent strains is widely studied as a model of generalized convulsive epilepsy. The molecular mechanisms that…”
Get full text

Rodent Models of Audiogenic Epilepsy: Genetic Aspects, Advantages, Current Problems and Perspectives by Garbuz, David G, Davletshin, Artem A, Litvinova, Svetlana A, Fedotova, Irina B, Surina, Natalya M, Poletaeva, Inga I

“…Animal models of epilepsy are of great importance in epileptology. They are used to study the mechanisms of epileptogenesis, and search for new genes and…”
Get full text

ERK1/2 kinases and dopamine D2 receptors participate in the anticonvulsant effects of a new derivative of benzoylpyridine oxime and valproic acid by Litvinova, Svetlana A., Voronina, Tatyana A., Kondrakhin, Evgeny A., Gaydukov, Igor O., Davletshin, Artem I., Vasileva, Ekaterina V., Kovalev, Georgy I., Garbuz, David G.

“…Inhibition of the activity of extracellular signal-regulated kinases (ERK1/2) induced by the activation of the dopamine D2 receptor signalling cascade may be a…”
Get full text

Innovational Development for Transitional Economy - Russia Case Study by Arsenyevа, Valeria A, Litvinova, Svetlana A, Parakhina, Valentina N, Kozenko, Zinaida N, Denisov, Mikhail Y

“…The purpose of this article is to develop mechanisms of innovational development for countries with transitional economies. The methodological base of the…”
Get full text

Pharmacological Analysis of GABA A Receptor and Sigma1R Chaperone Interaction: Research Report I-Investigation of the Anxiolytic, Anticonvulsant and Hypnotic Effects of Allosteric GABA A Receptors' Ligands by Voronin, Mikhail V, Shangin, Stanislav V, Litvinova, Svetlana A, Abramova, Elena V, Kurbanov, Rustam D, Rybina, Inna V, Vakhitova, Yulia V, Seredenin, Sergei B

“…Two groups of facts have been established in previous drug development studies of the non-benzodiazepine anxiolytic fabomotizole. First, fabomotizole prevents…”
Get full text

Comparison of effects and electrophysiological mechanisms of action of valproic acid and levetyracetam in an experimental model of focal epilepsy by Svetlana A. Litvinova, Georgii G. Avakyan, Tatyana А. Voronina, Igor O. Gaidukov, Lyubov N. Nerobkova, Inga S. Kutepova, Gagik N. Avakyan

“…Introduction. Despite rapid development of the antiepileptic pharmaceuticals market, about 2/3 of patients suffering from epilepsy do not receive adequate…”
Get full text

New approaches in the treatment of epilepsy by Georgiy G. Avakyan, Tat'yana A. Voronina, Svetlana A. Litvinova, Lyubov N. Nerobkova, Vadim Yu. Balabanyan, Anastasiya A. Nikonova, Gagik N. Avakyan

“…Introduction. Despite the significant progress made in the treatment of epilepsy in recent years, no less than 3040% of patients cannot achieve complete…”
Get full text